Global Psoriasis Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Drug Class;

TNF Inhibitors, Interleukins Inhibitors, and Others.

By Type;

Plaque Psoriasis, Psoriatic Arthritis, and Others.

By Product;

Tumour Necrosis Factor Inhibitors - Adalimumab, Infliximab and Etanercept.

By Distrubution Channel;

Topicals - Over-The-Counter (OTC) Topicals, Topical Non-Steroids and Topical Steroids.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn154501046 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Psoriasis Treatment Market (USD Million), 2021 - 2031

In the year 2024, the Global Psoriasis Treatment Market was valued at USD 28,110.38 million. The size of this market is expected to increase to USD 49,535.08 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.4%.

The global psoriasis treatment market is experiencing robust growth driven by increasing disease prevalence, heightened awareness about the condition, and advancements in therapeutic options. Psoriasis is a chronic autoimmune disease characterized by red, scaly patches on the skin, affecting millions of people worldwide. The rising incidence of psoriasis, coupled with improved diagnostic capabilities, has led to a greater number of patients seeking medical care. Awareness campaigns and educational initiatives by healthcare organizations have also played a pivotal role in encouraging patients to pursue treatment, thereby expanding the market.

Advancements in psoriasis treatment have significantly improved the quality of life for patients. Traditional therapies such as topical corticosteroids and phototherapy have been complemented by newer, more effective systemic treatments, including biologics and small molecule inhibitors. Biologic drugs, which target specific components of the immune system, have been particularly transformative, offering substantial relief for moderate to severe cases of psoriasis. These innovations have not only enhanced treatment efficacy but also reduced the frequency and severity of side effects, making long-term management more feasible for patients.

Looking forward, the psoriasis treatment market is poised for further growth driven by ongoing research and development. Pharmaceutical companies are actively pursuing the development of novel therapies, including next-generation biologics and biosimilars, to improve patient outcomes and expand treatment options. Additionally, the integration of personalized medicine approaches, which tailor treatments based on individual genetic and molecular profiles, is expected to further refine and optimize psoriasis management. As these advancements continue to emerge, the global psoriasis treatment market will likely see sustained expansion, benefiting patients with more effective and targeted therapeutic options.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Type
    3. Market Snapshot, By Product
    4. Market Snapshot, By Distrubution Channel
    5. Market Snapshot, By Region
  4. Global Psoriasis Treatment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Disease Prevalence
        2. Advancements in Therapeutic Options
        3. Rising Awareness and Diagnosis
      2. Restraints
        1. High Cost of Biologic Therapies
        2. Side Effects Associated with Treatments
        3. Stringent Regulatory Requirements
      3. Opportunities
        1. Development of Novel Therapies
        2. Growth of Biosimilars Market
        3. Personalized Medicine Approaches
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Psoriasis Treatment Market, By Drug Class, By Product, 2021 - 2031 (USD Million)
      1. TNF Inhibitors
      2. Interleukins Inhibitors
      3. Others
    2. Global Psoriasis Treatment Market, By Type, By Product, 2021 - 2031 (USD Million)
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    3. Global Psoriasis Treatment Market, By Product, 2021 - 2031 (USD Million)
      1. Tumour Necrosis Factor Inhibitors
        1. Adalimumab
        2. Infliximab
        3. Etanercept
    4. Global Psoriasis Treatment Market, By Distrubution Channel, 2021 - 2031 (USD Million)
      1. Topicals
        1. Over-The-Counter (OTC) Topicals
        2. Topical Non-Steroids
        3. Topical Steroids
    5. Global Psoriasis Treatment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Johnson & Johnson
      2. Novartis International AG
      3. Pfizer Inc.
      4. Eli Lilly and Company
      5. Amgen Inc.
      6. AbbVie Inc.
      7. Merck & Co., Inc.
      8. Bristol-Myers Squibb
      9. Celgene Corporation
      10. UCB S.A.
  7. Analyst Views
  8. Future Outlook of the Market